SMT201500103B - Metodo per trattare la malattia da deposito di glicogeno - Google Patents

Metodo per trattare la malattia da deposito di glicogeno

Info

Publication number
SMT201500103B
SMT201500103B SM201500103T SM201500103T SMT201500103B SM T201500103 B SMT201500103 B SM T201500103B SM 201500103 T SM201500103 T SM 201500103T SM 201500103 T SM201500103 T SM 201500103T SM T201500103 B SMT201500103 B SM T201500103B
Authority
SM
San Marino
Prior art keywords
storage disease
glycogen storage
treating glycogen
treating
disease
Prior art date
Application number
SM201500103T
Other languages
English (en)
Inventor
Yuan-Tsong Chen
Priya Kishnani
Baodong Sun
Original Assignee
Univ Duke
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Duke filed Critical Univ Duke
Publication of SMT201500103B publication Critical patent/SMT201500103B/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2405—Glucanases
    • C12N9/2408—Glucanases acting on alpha -1,4-glucosidic bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/0102—Alpha-glucosidase (3.2.1.20)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Transplantation (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Diabetes (AREA)
  • Neurology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SM201500103T 2008-07-08 2015-04-27 Metodo per trattare la malattia da deposito di glicogeno SMT201500103B (it)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12961208P 2008-07-08 2008-07-08
PCT/US2009/003993 WO2010005565A2 (en) 2008-07-08 2009-07-08 Method of treating glycogen storage disease

Publications (1)

Publication Number Publication Date
SMT201500103B true SMT201500103B (it) 2015-07-09

Family

ID=41507636

Family Applications (1)

Application Number Title Priority Date Filing Date
SM201500103T SMT201500103B (it) 2008-07-08 2015-04-27 Metodo per trattare la malattia da deposito di glicogeno

Country Status (12)

Country Link
US (5) US9050333B2 (it)
EP (1) EP2318037B1 (it)
CY (1) CY1116216T1 (it)
DK (1) DK2318037T3 (it)
ES (1) ES2535461T3 (it)
HR (1) HRP20150414T1 (it)
HU (1) HUE025212T2 (it)
PL (1) PL2318037T3 (it)
PT (1) PT2318037E (it)
SI (1) SI2318037T1 (it)
SM (1) SMT201500103B (it)
WO (1) WO2010005565A2 (it)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10017581B2 (en) 2013-02-20 2018-07-10 Valerion Therapeutics, Llc Methods and compositions for treatment of Pompe disease
US20180326021A1 (en) * 2015-08-31 2018-11-15 Duke University Methods and Compositions for the Treatment of Cytoplasmic Glycogen Storage Disorders
US10940125B2 (en) 2015-09-18 2021-03-09 Duke University Methods and compositions for the treatment of steatosis-associated disorders
IL299325A (en) 2016-09-12 2023-02-01 Inst Nat Sante Rech Med Variants of acid alpha glucosidase and their uses
EP3293259A1 (en) 2016-09-12 2018-03-14 Genethon Acid-alpha glucosidase variants and uses thereof
EP3293203A1 (en) 2016-09-12 2018-03-14 Genethon Acid-alpha glucosidase variants and uses thereof
EP3293260A1 (en) 2016-09-12 2018-03-14 Genethon Acid-alpha glucosidase variants and uses thereof
US20180207193A1 (en) * 2017-01-24 2018-07-26 Duke University Compositions and methods for improving enzyme replacement therapy for lysosomal storage diseases
BR112019025224A2 (pt) * 2017-05-31 2020-12-08 Ultragenyx Pharmaceutical Inc. Terapêutica para doença de armazenamento de glicogênio tipo iii

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2353522A1 (en) * 1998-12-07 2000-06-15 Pharming Intellectual Property B.V. Treatment of pompe's disease
PT1301201E (pt) 2000-07-18 2007-03-30 Univ Duke Tratamento da doença de armazenamento de glicogénio tipo ii

Also Published As

Publication number Publication date
DK2318037T3 (en) 2015-05-04
HRP20150414T1 (hr) 2015-06-19
US9850474B2 (en) 2017-12-26
EP2318037A4 (en) 2012-03-07
ES2535461T3 (es) 2015-05-11
US10647969B2 (en) 2020-05-12
US20180073003A1 (en) 2018-03-15
HUE025212T2 (en) 2016-03-29
US9050333B2 (en) 2015-06-09
WO2010005565A3 (en) 2010-05-14
EP2318037A2 (en) 2011-05-11
PL2318037T3 (pl) 2015-07-31
EP2318037B1 (en) 2015-01-28
PT2318037E (pt) 2015-05-20
US11214782B2 (en) 2022-01-04
US20110104187A1 (en) 2011-05-05
WO2010005565A2 (en) 2010-01-14
US20200299663A1 (en) 2020-09-24
SI2318037T1 (sl) 2015-07-31
CY1116216T1 (el) 2017-02-08
US20160122733A1 (en) 2016-05-05
US20220106579A1 (en) 2022-04-07

Similar Documents

Publication Publication Date Title
SMT201500103B (it) Metodo per trattare la malattia da deposito di glicogeno
BRPI0912337A2 (pt) composto método para melhorar memória em paciente, e, método para tratar condições
BRPI0923090A2 (pt) método implementado por computador
IL207892A0 (en) Agent for treating disease
HK1151533A1 (zh) 種治療疾病的試劑
ZA201007215B (en) Agent for treating disease
BRPI0919116A2 (pt) método
SMT201500171B (it) Metodo per trattare la fibrillazione atriale
IL211140A0 (en) Method of identifying disease risk factor
BRPI0910854A2 (pt) métodos de tratamento
BRPI0909541A2 (pt) ''método para tratamento de doenças inflamatórias do cólon''
BRPI0917575A2 (pt) métodos de tratamento de talassemia
BR112012005117A2 (pt) método de tratamento de esofagite eosinofílica
DK2313489T3 (da) Fremstillingsmetode
BRPI0911077A2 (pt) método para tratamento de biomassa
BRPI0908715A2 (pt) métodos para tratamento da psoríase
BRPI0822129A2 (pt) Inibidores de aldh-2c no tratamento de vício.
BRPI0916597A2 (pt) Método
HK1154797A1 (en) Composition for treating disease
IT1391060B1 (it) Metodo e macchina per la verifica di contenitori.
BRPI0914170A2 (pt) recipiente para produtos médicos e método para produção do referido recipiente
EP2354223A4 (en) NUCLEIC ACID DRUG TO TREAT AN ALLERGIC DISEASE
DE602008003969D1 (de) Überprüfungsverfahren
IT1393574B1 (it) Apparato di trattamento di contenitori
ZA201104003B (en) Drug for treating infections